Post Inflammtory Erythema

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Post Inflammtory Erythema trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingEarly Phase 1

NCT07474883

Efficacy of 0.5% Topical Timolol Eye Drops in the Treatment of Post-Inflammatory Erythema Following Acne Vulgaris

Post-inflammatory erythema (PIE) is a common sequela of acne vulgaris, characterized by persistent erythematous macules resulting from superficial vascular dila…

Vietnam60 participantsStarted 2026-03-09

Treatment: Timolol 0.5% Ophthalmic Solution, Intense Pulsed Light

Post Inflammtory Erythema

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Efficacy of 0.5% Topical Timolol Eye Drops in the Treatment of Post-Inflammatory Erythema Following Acne Vulgaris

All recent trials (1 shown)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Efficacy of 0.5% Topical Timolol Eye Drops in the Treatment of Post-Inflammatory Erythema Following Acne Vulgaris

All recent trials (1 shown)